ALT - Lilly Novo Nordisk to dominate weight loss therapy market: SA Investing Summit June, 23 2024 02:00 PM Altimmune Inc. 2024-06-23 14:00:00 ET More on Eli Lilly, Novo Nordisk Eli Lilly: The Party Is Probably Nearing The End Novo Nordisk: Leading The Fight Against Diabetes And Obesity SA Asks: Who will launch the next big weight-loss drug? SA Asks: Is Eli Lilly or Novo Nordisk a better investment? Lilly weight loss drug tirzepatide meets primary endpoint in sleep apnea study For further details see: Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit